Cargando…

What biomarkers (if any) for precise medicine?

Detalles Bibliográficos
Autores principales:	Strano, Sabrina, Muti, Paola, Blandino, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586099/ https://www.ncbi.nlm.nih.gov/pubmed/26319119

Ejemplares similares

Mir 145/143: tumor suppressor, oncogenic microenvironmental factor or …both?
por: Cioce, Mario, et al.
Publicado: (2016)

Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
por: Lo Sardo, Federica, et al.
Publicado: (2017)

Dihydroartemisinin: from malaria to the treatment of relapsing head and neck cancers
por: Pulito, Claudio, et al.
Publicado: (2020)

Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention
por: Pulito, Claudio, et al.
Publicado: (2013)

MicroRNA-181a/b: Novel biomarkers to stratify breast cancer patients for PARPi treatment
por: Mori, Federica, et al.
Publicado: (2013)

MicroRNAs: short non-coding players in cancer chemoresistance
por: Donzelli, Sara, et al.
Publicado: (2014)

CircRNAs: role in human diseases and potential use as biomarkers
por: Verduci, Lorena, et al.
Publicado: (2021)

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma
por: Di Agostino, Silvia, et al.
Publicado: (2018)

Depression and Inflammation: Is There any Role for Biomarkers?
por: Akhondzadeh, Shahin
Publicado: (2019)

microRNAs: short non-coding bullets of gain of function mutant p53 proteins
por: Donzelli, Sara, et al.
Publicado: (2014)

Metformin-induced metabolic reprogramming of chemoresistant ALDH(bright) breast cancer cells
por: Cioce, Mario, et al.
Publicado: (2014)

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
por: Sacconi, Andrea, et al.
Publicado: (2023)

Gender, mutant p53 and PML: A growing “affaire” in tumor suppression and oncogenesis
por: Di Agostino, Silvia, et al.
Publicado: (2013)

YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
por: Lo Sardo, Federica, et al.
Publicado: (2018)

In Vivo Biomarker Imaging: Paving the Way for Precision Medicine
por: Liu, Guanshu, et al.
Publicado: (2023)

COVID-19 Test Before Tokyo2020 Paralympic Games: An Implemented Protocol to Protect Paralympic Athletes
por: Muti, Greta E., et al.
Publicado: (2022)

miR-181c associates with tumor relapse of high grade osteosarcoma
por: Federica, Mori, et al.
Publicado: (2015)

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects
por: Mori, Federica, et al.
Publicado: (2016)

Toward Precision Medicine: How Far Is the Goal?
por: Ravegnini, Gloria, et al.
Publicado: (2016)

Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia
por: Donzelli, Sara, et al.
Publicado: (2020)

Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2017)

The circRNA–microRNA code: emerging implications for cancer diagnosis and treatment
por: Verduci, Lorena, et al.
Publicado: (2019)

From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We?
por: Tondo, Giacomo, et al.
Publicado: (2022)

Cdx2 Polymorphism Affects the Activities of Vitamin D Receptor in Human Breast Cancer Cell Lines and Human Breast Carcinomas
por: Pulito, Claudio, et al.
Publicado: (2015)

Understanding the Precision in “Precision Medicine”
por: Chabner, Bruce A.
Publicado: (2016)

Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancer
por: Ghiringhelli, Francois, et al.
Publicado: (2018)

The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment
por: Macias, Rocio I. R., et al.
Publicado: (2023)

Oncogenic Intra-p53 Family Member Interactions in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2016)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)

Precision Medicine
por: Pinho, João Renato Rebello
Publicado: (2017)

Precision medicine()
por: Nakanishi, Marcio
Publicado: (2018)

A Path to Precision Medicine: Incorporating Blood-Based Biomarkers in Stroke Rehabilitation
por: Oh, Byung-Mo
Publicado: (2021)

What’s in a name? That which we call sacroiliitis by any other name would look the same…
por: Tarantino, Alfredo, et al.
Publicado: (2018)

Precision Medicine for Endocrinology
por: Azizi, Fereidoun
Publicado: (2016)

The Conundrum of Giglio Island: Unraveling the dynamics of an apparent resistance to COVID-19 – A descriptive study
por: Bognanni, Antonio, et al.
Publicado: (2021)

Hippo and rassf1a Pathways: A Growing Affair
por: Fausti, Francesca, et al.
Publicado: (2012)

PML Surfs into HIPPO Tumor Suppressor Pathway
por: Strano, Sabrina, et al.
Publicado: (2013)

ID4: a new player in the cancer arena
por: Dell'Orso, Stefania, et al.
Publicado: (2010)

Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
por: Cioce, Mario, et al.
Publicado: (2020)

Are there any benefits of exercise training in cancer cachexia?
por: Argilés, Josep M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c8h8udrh12gi0rd9lg43rnns63